Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Rapid exchange of mammalian topoisomerase II alpha at kinetochores and chromosome arms in mitosis.

Tavormina PA, Côme MG, Hudson JR, Mo YY, Beck WT, Gorbsky GJ.

J Cell Biol. 2002 Jul 8;158(1):23-9. Epub 2002 Jul 8.

2.

The spindle checkpoint of the yeast Saccharomyces cerevisiae requires kinetochore function and maps to the CBF3 domain.

Gardner RD, Poddar A, Yellman C, Tavormina PA, Monteagudo MC, Burke DJ.

Genetics. 2001 Apr;157(4):1493-502.

4.
5.
6.

Lysostaphin: model for a specific enzymatic approach to infectious disease.

Zygmunt WA, Tavormina PA.

Prog Drug Res. 1972;16:309-33. Review. No abstract available.

PMID:
4265118
7.

Haloprogin: a topical antifungal agent.

Harrison EF, Zwadyk P Jr, Bequette RJ, Hamlow EE, Tavormina PA, Zygmunt WA.

Appl Microbiol. 1970 May;19(5):746-50.

8.

Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium.

Vigdahl RL, Marquis NR, Tavormina PA.

Biochem Biophys Res Commun. 1969 Oct 22;37(3):409-15.

PMID:
4310667
9.

Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1.

Marquis NR, Vigdahl RL, Tavormina PA.

Biochem Biophys Res Commun. 1969 Sep 10;36(6):965-72.

PMID:
4310150
10.

Optical configuration of staphylococcal cell wall serine.

Browder HP, Tavormina PA, Zygmunt WA.

J Bacteriol. 1968 Oct;96(4):1452-3. No abstract available.

11.

Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics.

Zygmunt WA, Browder HP, Tavormina PA.

Appl Microbiol. 1968 Aug;16(8):1168-73.

12.

Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics.

Zygmunt WA, Harrison EF, Browder HP, Tavormina PA.

Appl Microbiol. 1968 Aug;16(8):1174-8.

13.

Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.

Zygmunt WA, Browder HP, Tavormina PA.

Can J Microbiol. 1967 Jul;13(7):845-53. No abstract available.

PMID:
6036889
14.

Steroid interference with antifungal activity of polyene antibiotics.

Zygmunt WA, Tavormina PA.

Appl Microbiol. 1966 Nov;14(6):865-9.

15.

Growth inhibition of unusual strains of Staphylococcus aureus by lysostaphin and other antistaphylococcal antibiotics.

Zygmunt WA, Browder HP, Tavormina PA.

Can J Microbiol. 1966 Apr;12(2):341-5. No abstract available.

PMID:
5929159
16.

In vitro effect of lysostaphin, neomycin, and bacitracin on Staphylococcus aureus.

Zygmunt WA, Browder HP, Tavormina PA.

Can J Microbiol. 1966 Feb;12(1):204-6. No abstract available.

PMID:
5923134
17.

DL-S-Trifluoromethylhomocysteine, a novel inhibitor of microbial growth.

Zygmunt WA, Tavormina PA.

Can J Microbiol. 1966 Feb;12(1):143-8. No abstract available.

PMID:
5332226
18.

LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.

BROWDER HP, ZYGMUNT WA, YOUNG JR, TAVORMINA PA.

Biochem Biophys Res Commun. 1965 Apr 23;19:383-9. No abstract available.

PMID:
14317407
19.

Influence of blood and serum on the antistaphylococcal activity of lysostaphin.

Sygmunt WA, Browder HP, Tavormina PA.

J Bacteriol. 1966 Feb;91(2):725-8.

20.

Biochemistry of the sphingolipides. VI. The o-methyl ethers of sphingosine.

CARTER HE, NALBANDOV O, TAVORMINA PA.

J Biol Chem. 1951 Sep;192(1):197-207. No abstract available.

Supplemental Content

Loading ...
Support Center